Replicating viral vector platform exploits alarmin signals for potent CD8+ T cell-mediated tumour immunotherapy-Reference-Cited by-同舟云学术

Replicating viral vector platform exploits alarmin signals for potent CD8+ T cell-mediated tumour immunotherapy

Published:2017-05-26 Issue:1 Volume:8 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Kallert Sandra M.,Darbre Stephanie,Bonilla Weldy V.,Kreutzfeldt Mario,Page Nicolas,Müller Philipp,Kreuzaler Matthias,Lu Min,Favre Stéphanie,Kreppel Florian,Löhning Max,Luther Sanjiv A.,Zippelius Alfred,Merkler Doron,Pinschewer Daniel D.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/ncomms15327.pdf

Reference70 articles.

1. Andtbacka, R. H. et al. Talimogene laherparepvec improves durable response rate in patients with advanced melanoma. J. Clin. Oncol. 33, 2780–2788 (2015).

2. Sharma, P. & Allison, J. P. The future of immune checkpoint therapy. Science 348, 56–61 (2015).

3. Klebanoff, C. A., Rosenberg, S. A. & Restifo, N. P. Prospects for gene-engineered T cell immunotherapy for solid cancers. Nat. Med. 22, 26–36 (2016).

4. Kantoff, P. W. et al. Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N. Engl. J. Med. 363, 411–422 (2010).

5. Vansteenkiste, J. F. et al. Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 17, 822–835 (2016).

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Flt3 agonist enhances immunogenicity of arenavirus vector-based simian immunodeficiency virus vaccine in macaques;Journal of Virology;2024-07-23

2. Arenavirus-Based Vectors Generate Robust SIV Immunity in Non-Human Primates;Vaccines;2024-07-02

3. An attenuated lymphocytic choriomeningitis virus vector enhances tumor control in mice partly via IFN-I;Journal of Clinical Investigation;2024-06-11

4. Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C;Journal for ImmunoTherapy of Cancer;2024-04

5. Preclinical evaluation of two phylogenetically distant arenavirus vectors for the development of novel immunotherapeutic combination strategies for cancer treatment;Journal for ImmunoTherapy of Cancer;2024-04